Results 291 to 300 of about 74,157 (302)

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Nature Reviews Drug Discovery, 2011
Hagop Kantarjian, Jorge Cortes, Srdan Verstovsek   +2 more
exaly  

Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis

Autoimmunity Reviews, 2023
exaly  

Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses

Frontiers in Immunology
Jinhao Zeng
exaly  

Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors

Mini-Reviews in Medicinal Chemistry, 2019
Jun Dai
exaly  

Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study

Frontiers in Immunology
Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht   +2 more
exaly  

Janus Kinase Inhibitors

openaire   +1 more source

Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series

Frontiers in Pharmacology
Polona Jaki Mekjavić
exaly  

Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature

Seminars in Arthritis and Rheumatism
Veysel Cam, Ezgi Deniz Batu
exaly  

Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis

Journal of Dermatological Treatment
Bai-Lin Chen, Yuan-Yuan Chen
exaly  

Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study

Seminars in Arthritis and Rheumatism
Lieke E J M Scheepers, Graeme Jones
exaly